{"ticker": {"uuid": "ad03440c-d307-4ae8-9972-1e8221c8867d", "symbol": "ZNTL", "name": "Zentalis Pharmaceuticals\u00a0Llc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Zentalis Pharmaceuticals (ZNTL) Edges Higher, Stabilizing Near Support After Recent Volatility - Entry Point Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQY083US1oTGRSdktNNkJIRzRLbERyNnNFbXRTM2t4RVVmSW1RODhqQkZ2TUxmVDlBMDFuOHZ0VHRsanE5QUZaVkRfZHpOa21fU19rczMxRVgzU2xxX1MtaDJzUUF2T1VwMnkzbXZMeXRsT1J5TUJQZ3RwclRnQW8ybjdSb1Zqa05aTW9JS2dHckhuc08zT2xqVll4QlhKNC1BSDhUWEh2T1dsemF6dFpncGxNMldJMWZuS2dKTjJqcmtsdXdYZ0U4R3NVOWZRQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-14T19:44:10+00:00", "published_display": "14 Jul 2026 19:44", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zentalis Pharmaceuticals outlines oncology pipeline strategy as clinical programs advance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNYXNLTVRHYlNQWFNXbFpid0kzY1BqU3pWT0YySFhuaGV4enNrRE1kUmdOSHBLV0pQb0xVRFhwZ2UzSlBZTVVmLWtLbUZTRW5xMG96Y29vRVhNeFVnOTZubmZzMDlHdmdlUzQ3NmhXaWkwdDdhR2NWSXVOUmE4RDVueGNyQkVLZ0VQOGFDMERHWXplN2piV3ppNFRvY3cxaVNnYmEwVnluQ1NKX1hPM3ZQVHIwZW1NNGxqOXV5QnRkRy1XYnU5OTJTNHZUZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-07T16:11:50+00:00", "published_display": "07 Jul 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals (ZNTL) director granted 57,100 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPLVdJVDZsajR4bC1IUjg0bjRlWjN1LTZ2ODBrb0hJWVZzVlpsS2hZUU5fbU5EX19XOUduSldrNnQ4WmdmSnNEeDgtZDY3LWFoLS1lVTJ4WUtNV2VzaS1zQUNNa3NjdC1VaXNiVVd1ZGVYTkhuUk5kejF1TTV2VV9HNDV1UUFtTjJYbkdJSkZaNXNXU3BzeFRGeDlaM3RMT0t3c0Z1UDd6OUFfSWdLTkIyS0hOM2hNb0xHRjVkWTlLUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis (ZNTL) director Enoch Kariuki granted 57,100 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNU3FDRUs2ajFsbm5qQmgzTWlzT3V0M05KMExmZU1KUXQyamdvVGgwQ1JVcWQ4NTRaWXhOYWo5S0YxVW9RLUUyY1RsUDZJaWNINWItamJrYklBVGZlcFFPZGI1MjY2QUxqMVlVUGNwemp5QXFKTWJlLTcxNmYyZldXNjdTUjM1NkVyYVExQXJpRmhGNGhxYXh1LVNpSFEzRXNYVW9IdF93NVFEVWIybDBUUEJ3Ul9hbl9FUzBKLWVfOA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Insider Sellers Vindicated After 10% Drop", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zentalis-pharmaceuticals-announces-inducement-grants-210000657.html", "source_name": "GlobeNewswire", "published_at": "2026-06-01T21:00:00+00:00", "published_display": "01 Jun 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-strengthens-commercial-leadership-appointments-200500216.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T20:05:00+00:00", "published_display": "27 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-present-phase-1b-213900910.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T21:39:00+00:00", "published_display": "21 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/news/zentalis-pharmaceuticals-participate-upcoming-investor-200500038.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T20:05:00+00:00", "published_display": "13 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-reports-first-quarter-200500068.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:05:00+00:00", "published_display": "12 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-announces-first-patient-120000603.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T12:00:00+00:00", "published_display": "05 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zentalis-pharmaceuticals-announces-inducement-grant-213000684.html", "source_name": "GlobeNewswire", "published_at": "2026-05-01T21:30:00+00:00", "published_display": "01 May 2026 21:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-announces-abstract-acceptance-142700135.html", "source_name": "GlobeNewswire", "published_at": "2026-04-21T14:27:00+00:00", "published_display": "21 Apr 2026 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zentalis (ZNTL) Locks In Its Cancer Drug Dose; Jefferies Raises the Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNVm1iVjB2R1dLXy1sdHM4TjFoZy1aS0dTcGpnY09EOGtEYko0MW1XdkF6NEppZTFBUXpQY2NDLXl1LURqSmtjLUtXRXM5TkJHU2Zid0UxY19HcXRnUDZOcXVrejgwN3hIRUd1TW8yaGhxdmN0aTJfcVhDTWlaaTZ5LTBrb1lqTlpIV2xvTlU1dlZEN0ltUEhKSVRsS1d2Wmc0Vnc?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-present-azenosertib-preclinical-191500686.html", "source_name": "GlobeNewswire", "published_at": "2026-04-17T19:15:00+00:00", "published_display": "17 Apr 2026 19:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Dose Selection News", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Dose Selection Milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPajlpZm1MVG1JOTRWMUxyd1MtYnBRMFVxcWU5V3dhMU9oMV9nVFRZd2dMa0ZkU1ltWDlhU1pvOS16T2swQVJEQ0dqSU9NM2lMQXdUZDE4OHlKaGpVSkFiYm1LT1Z2U0tCdW80RHpoLUJUOTZIbEJZUkJsMF9NU1l0QzkzY3g5OXQ3T3ZTTkhHUnNXT3pLSUdEU3psT1VLdlZLUklZSlJPaGN3QU1Ga29aYkJGYw?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Stock Jumps as Guggenheim Lifts Price Target on Cancer Program Success", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNanNnQ21ZVmhHa3BLUFRmb2hHaWtuTlA0N3lHbHhPbml1SEliaFBnU3A0eGxqOURNWFRKVHM2cUNKeFpHU1VWWTR3ZTNNYTFwc3VNRDdHRDNXRmRoVV90TjNkZXhhUklTQ05UNi15aTdzbWRFOFpuNVlQWnpiV3g4MXBYM3ZMUQ?oc=5", "source_name": "StocksToTrade", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Zentalis (ZNTL) Using Azenosertib\u2019s New Dose To Reframe Its Ovarian Cancer Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxQRlhNMnVGbmRuVDF2cTh6R0Z5MUhpWm1XR2I1bmJRb1QxUGhXVmNfV0RWdEhlYkhfWEhDMnNva25qbzh2UTVIdHRJZTFXczI0NjlqYlY2a2JkaDd1enRuMDAwME1pNk8tbW1nNzdhWmVFTGQ3ODVWTmRoQ1BVcmdGMXdEZTBlZkxoQUUwb1dMay10UHp1UFN3TVk0YlE5bW80bVZuYlVYaGxFb1VWdVZqdmViMUpCYjFVNHNONlF4VVV0NlNGUFlrLU1qQ3NLYXdHenFtb3gwNUlSWkROczhjdGJfSktaNzIxd1dKZWlB0gHzAUFVX3lxTE1mQ19WaWE2SW9uTGNDUmtsRnNnRW5sWlZNU3g5OUplMGc2VkRIcmUtNDlBYVd3eXg2LXEyNDNEWXBac2tINDlfcUhFNERVR2poYW90dW5JMXlkMm90aldnekJ5VEpGUmtFSEgzTlI5SFpQb05aRzFDSmRQWjd2VEEtbW9qbWZ5WHo2cV92bzYyUXJSTV9tY0MxdFhiUlRXWVVkRGlTMExIbjBRZk9CampuV29wbC14bFU0M1I2NlExcUdjOVRKUGFMRGxvbi1QUFJuVE5KamJjd2VRUzJ2akJYSWUweWZwb3Z5MWdRblQxZEZKMA?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-11T07:00:00+00:00", "published_display": "11 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Behind The Surge In Zentalis Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPX3h5cmIyTm9VUGZkemVLV2JIMkdqeXQxRmltTXR5enZDM0ZJM1VwTzVYY1BhQ3lONnRScVpOX25IVGg3NWI0WHZ4Z2Z0T1gxYlJCUVpJTEtMMVc3NXRveE1PbzRaZXRPcnNTVlYxakJMV1I5bW1YbE5pbWNFcEhVTzlMNkxsU25DLXREZzdhdXV5emFMNmJZ?oc=5", "source_name": "Sahm", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zentalis Pharmaceuticals Stock (ZNTL) Opinions on Azenosertib Development Update | ZNTL Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSWtIejZ6NEZxMmJJeGZ6QjRZdENYZmZtZjVvZGluQ3NZLURDTDlDN0k5QVhDMHdoQ1ItWGRnNk5sOW1BeWREaG51UE9zZjhRY1diQWg4UF82eTZPWktHUWU3WGdaSkZLQ2JnTlNpakpZcWhZbF9sYzZTYVRmZi1fSmY5ZkxDS0c5c0lsa0ltYXFvY2pmdFFITnJkLWg4NUg2eWJrdkEyOERTUEx0UjFfWWVVMVdFMnZs?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Walters group buys Zentalis Pharmaceuticals (ZNTL) shares for $7.7m", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQUW5vQXB6enVXMldRQlBlQWxDMGNPM0RvVHZ0NFcyLXA0Ykpob1NYdXFRWHIyb1RYRzFQMlBrbExXaXIxT3NQMkRBYi13c1Vzb1pYb3ZKblBabU5NT2dwOGx6d3dxLWwzV3RGYmtfSm5nWEdzV1MwX2ltR21jZllUS3I2eTNSMmpZWFBCcktDYndFNUZvMy1BeU12Rnpra0tLVDFhbkpERzNwTGlPNlU4NlVGMTVxS2pqUVJWbFZRa3Y4TXV5d19n?oc=5", "source_name": "Investing.com", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Following a 13% decline over last year, recent gains may please Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) institutional owners", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPVmpPTWZVUHBVQURLZUhQY3FEVDZTZl9jSWVxN2xKWFVoMGpyNUxTZTRPTDV1V0twMnd6Q1Y5aHJoRHQzVEpMUEVYTU9vZi1hMHlNdU50aktyXzFrQUFkV1FGSGlRaGoxekhiMEw0d292emNnWTJ2akhMQUNYN0tCZmtB?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Shares Bounce 28% But Its Business Still Trails The Industry", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Zentalis Pharmaceuticals (ZNTL) Edges Higher, Stabilizing Near Support After Recent Volatility - Entry Point Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQY083US1oTGRSdktNNkJIRzRLbERyNnNFbXRTM2t4RVVmSW1RODhqQkZ2TUxmVDlBMDFuOHZ0VHRsanE5QUZaVkRfZHpOa21fU19rczMxRVgzU2xxX1MtaDJzUUF2T1VwMnkzbXZMeXRsT1J5TUJQZ3RwclRnQW8ybjdSb1Zqa05aTW9JS2dHckhuc08zT2xqVll4QlhKNC1BSDhUWEh2T1dsemF6dFpncGxNMldJMWZuS2dKTjJqcmtsdXdYZ0U4R3NVOWZRQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-14T19:44:10+00:00", "published_display": "14 Jul 2026 19:44", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals outlines oncology pipeline strategy as clinical programs advance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNYXNLTVRHYlNQWFNXbFpid0kzY1BqU3pWT0YySFhuaGV4enNrRE1kUmdOSHBLV0pQb0xVRFhwZ2UzSlBZTVVmLWtLbUZTRW5xMG96Y29vRVhNeFVnOTZubmZzMDlHdmdlUzQ3NmhXaWkwdDdhR2NWSXVOUmE4RDVueGNyQkVLZ0VQOGFDMERHWXplN2piV3ppNFRvY3cxaVNnYmEwVnluQ1NKX1hPM3ZQVHIwZW1NNGxqOXV5QnRkRy1XYnU5OTJTNHZUZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-07T16:11:50+00:00", "published_display": "07 Jul 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals (ZNTL) director granted 57,100 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPLVdJVDZsajR4bC1IUjg0bjRlWjN1LTZ2ODBrb0hJWVZzVlpsS2hZUU5fbU5EX19XOUduSldrNnQ4WmdmSnNEeDgtZDY3LWFoLS1lVTJ4WUtNV2VzaS1zQUNNa3NjdC1VaXNiVVd1ZGVYTkhuUk5kejF1TTV2VV9HNDV1UUFtTjJYbkdJSkZaNXNXU3BzeFRGeDlaM3RMT0t3c0Z1UDd6OUFfSWdLTkIyS0hOM2hNb0xHRjVkWTlLUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis (ZNTL) director Enoch Kariuki granted 57,100 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNU3FDRUs2ajFsbm5qQmgzTWlzT3V0M05KMExmZU1KUXQyamdvVGgwQ1JVcWQ4NTRaWXhOYWo5S0YxVW9RLUUyY1RsUDZJaWNINWItamJrYklBVGZlcFFPZGI1MjY2QUxqMVlVUGNwemp5QXFKTWJlLTcxNmYyZldXNjdTUjM1NkVyYVExQXJpRmhGNGhxYXh1LVNpSFEzRXNYVW9IdF93NVFEVWIybDBUUEJ3Ul9hbl9FUzBKLWVfOA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Insider Sellers Vindicated After 10% Drop", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zentalis-pharmaceuticals-announces-inducement-grants-210000657.html", "source_name": "GlobeNewswire", "published_at": "2026-06-01T21:00:00+00:00", "published_display": "01 Jun 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-strengthens-commercial-leadership-appointments-200500216.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T20:05:00+00:00", "published_display": "27 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-present-phase-1b-213900910.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T21:39:00+00:00", "published_display": "21 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/news/zentalis-pharmaceuticals-participate-upcoming-investor-200500038.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T20:05:00+00:00", "published_display": "13 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-reports-first-quarter-200500068.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:05:00+00:00", "published_display": "12 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-announces-first-patient-120000603.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T12:00:00+00:00", "published_display": "05 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zentalis-pharmaceuticals-announces-inducement-grant-213000684.html", "source_name": "GlobeNewswire", "published_at": "2026-05-01T21:30:00+00:00", "published_display": "01 May 2026 21:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-announces-abstract-acceptance-142700135.html", "source_name": "GlobeNewswire", "published_at": "2026-04-21T14:27:00+00:00", "published_display": "21 Apr 2026 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis (ZNTL) Locks In Its Cancer Drug Dose; Jefferies Raises the Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNVm1iVjB2R1dLXy1sdHM4TjFoZy1aS0dTcGpnY09EOGtEYko0MW1XdkF6NEppZTFBUXpQY2NDLXl1LURqSmtjLUtXRXM5TkJHU2Zid0UxY19HcXRnUDZOcXVrejgwN3hIRUd1TW8yaGhxdmN0aTJfcVhDTWlaaTZ5LTBrb1lqTlpIV2xvTlU1dlZEN0ltUEhKSVRsS1d2Wmc0Vnc?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/zentalis-pharmaceuticals-present-azenosertib-preclinical-191500686.html", "source_name": "GlobeNewswire", "published_at": "2026-04-17T19:15:00+00:00", "published_display": "17 Apr 2026 19:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Dose Selection News", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Dose Selection Milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPajlpZm1MVG1JOTRWMUxyd1MtYnBRMFVxcWU5V3dhMU9oMV9nVFRZd2dMa0ZkU1ltWDlhU1pvOS16T2swQVJEQ0dqSU9NM2lMQXdUZDE4OHlKaGpVSkFiYm1LT1Z2U0tCdW80RHpoLUJUOTZIbEJZUkJsMF9NU1l0QzkzY3g5OXQ3T3ZTTkhHUnNXT3pLSUdEU3psT1VLdlZLUklZSlJPaGN3QU1Ga29aYkJGYw?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Stock Jumps as Guggenheim Lifts Price Target on Cancer Program Success", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNanNnQ21ZVmhHa3BLUFRmb2hHaWtuTlA0N3lHbHhPbml1SEliaFBnU3A0eGxqOURNWFRKVHM2cUNKeFpHU1VWWTR3ZTNNYTFwc3VNRDdHRDNXRmRoVV90TjNkZXhhUklTQ05UNi15aTdzbWRFOFpuNVlQWnpiV3g4MXBYM3ZMUQ?oc=5", "source_name": "StocksToTrade", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Zentalis (ZNTL) Using Azenosertib\u2019s New Dose To Reframe Its Ovarian Cancer Strategy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-11T07:00:00+00:00", "published_display": "11 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Behind The Surge In Zentalis Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPX3h5cmIyTm9VUGZkemVLV2JIMkdqeXQxRmltTXR5enZDM0ZJM1VwTzVYY1BhQ3lONnRScVpOX25IVGg3NWI0WHZ4Z2Z0T1gxYlJCUVpJTEtMMVc3NXRveE1PbzRaZXRPcnNTVlYxakJMV1I5bW1YbE5pbWNFcEhVTzlMNkxsU25DLXREZzdhdXV5emFMNmJZ?oc=5", "source_name": "Sahm", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals Stock (ZNTL) Opinions on Azenosertib Development Update | ZNTL Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSWtIejZ6NEZxMmJJeGZ6QjRZdENYZmZtZjVvZGluQ3NZLURDTDlDN0k5QVhDMHdoQ1ItWGRnNk5sOW1BeWREaG51UE9zZjhRY1diQWg4UF82eTZPWktHUWU3WGdaSkZLQ2JnTlNpakpZcWhZbF9sYzZTYVRmZi1fSmY5ZkxDS0c5c0lsa0ltYXFvY2pmdFFITnJkLWg4NUg2eWJrdkEyOERTUEx0UjFfWWVVMVdFMnZs?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Walters group buys Zentalis Pharmaceuticals (ZNTL) shares for $7.7m", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQUW5vQXB6enVXMldRQlBlQWxDMGNPM0RvVHZ0NFcyLXA0Ykpob1NYdXFRWHIyb1RYRzFQMlBrbExXaXIxT3NQMkRBYi13c1Vzb1pYb3ZKblBabU5NT2dwOGx6d3dxLWwzV3RGYmtfSm5nWEdzV1MwX2ltR21jZllUS3I2eTNSMmpZWFBCcktDYndFNUZvMy1BeU12Rnpra0tLVDFhbkpERzNwTGlPNlU4NlVGMTVxS2pqUVJWbFZRa3Y4TXV5d19n?oc=5", "source_name": "Investing.com", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Following a 13% decline over last year, recent gains may please Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) institutional owners", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPVmpPTWZVUHBVQURLZUhQY3FEVDZTZl9jSWVxN2xKWFVoMGpyNUxTZTRPTDV1V0twMnd6Q1Y5aHJoRHQzVEpMUEVYTU9vZi1hMHlNdU50aktyXzFrQUFkV1FGSGlRaGoxekhiMEw0d292emNnWTJ2akhMQUNYN0tCZmtB?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Shares Bounce 28% But Its Business Still Trails The Industry", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 73, "total_relevant": 32, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 27, "score": 52, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 11.55, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 3.85, "count": 9}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 4.88, "latest_week": "2026-07-10", "one_week_move": 9.4, "four_week_move": 30.1, "twelve_week_move": 5.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.110106, "market_dynamics_buy_signal": false, "relative_strength": 69.108925, "fair_value_gap": -27.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.7301, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+9.4% over one week, +30.1% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GlobeNewswire", "count": 9}, {"label": "Market source", "count": 8}, {"label": "simplywall.st", "count": 6}, {"label": "Stock Titan", "count": 2}, {"label": "dars.gov.et", "count": 1}, {"label": "Ad-hoc-news.de", "count": 1}, {"label": "StocksToTrade", "count": 1}, {"label": "Sahm", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 24}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 9}, {"label": "Analyst action", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "24", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+9.4% over one week, +30.1% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Zentalis Pharmaceuticals (ZNTL) Edges Higher, Stabilizing Near Support After Recent Volatility - Entry Point Alerts"}], "updated_at": "2026-07-16T06:04:41.786269+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}